Catheter Access Articles & Analysis
33 news found
In addition, hydrophilic coatings can be used within interventional medical devices of the cardiovascular, circulatory, nervous, urinary, and vascular system, which include inner and outer surfaces of stents, separators, lenses, guide wires, needles, vascular access, implants, urinary catheters, balloons, and catheters. CD Bioparticles offers a ...
US Patent No. 9,861,805 B2 covers wide-ranging claims behind the needless connector for use in medical access devices such as IV catheters. “The patent issuance comes at an exciting time for our company, as many assets are evolving from speculative to tangible,” said founder and Chief Executive Officer Ryan Dennis, M.D. “The breadth of our ...
Alexandros Mallios, Director, Vascular Access Center at the Hôpital Paris Saint-Joseph in Paris, France and his team. “Our paper is the first to report on a fully extraanatomical, minimally invasive approach resulting in the bridging of a functioning upper extremity access to the SVC,” stated Dr. Mallios. “The use of the Surfacer System ...
“The Surfacer Inside-out system represents a new approach to restore right-sided central venous access in chronic thoracic venous occlusion by the inside-out recanalization technique” stated Dr. ...
This QDIP designation applies to the use of BTX 1901 to potentially ‘reduce the risk of Staph. aureus bloodstream infections in colonised patients dependent on central venous catheters for hemodialysis’, the lead indication for our novel intranasal gel. ...
“We appreciate the ongoing support of our loyal shareholders and the trust new investors have placed in the company as it underscores their commitment and alignment with our vision to improve central venous access related patient outcomes and reduce healthcare costs.” The Surfacer System employs the novel Inside-Out approach and is the first FDA cleared medical ...
The Singapore site has been serving the medical device industry since 2004, focusing on minimally invasive products such as catheters and access sheaths, making this very compatible and complementary. ...
Using the Surfacer System, we were able to cross the patient’s central venous occlusion and obtain central venous access which facilitated the placement of a Hemodialysis Reliable Outflow (HeRO) graft and removal of their femoral catheter.” “Utilizing the Surfacer System to facilitate gaining central venous access and avoid the ...
The paper, published in the Journal of Vascular Access, demonstrated the ability to gain long-term vascular access without any significant complications or adverse events from the procedure with the benefit of avoiding the placement of a femoral catheter with its associated disadvantages. ...
This prospective, multi-center clinical trial is the first study designed to evaluate the clinical benefits of direct aspiration for the treatment of ischemic stroke with the Zoom 88 Large Distal Platform, which is currently FDA cleared for neurovascular access. Additionally, the trial will gather data on the clinical benefits of the full Zoom Stroke Solution™, the ...
” Thoracic central venous obstruction occurs in roughly 40% of patients where hemodialysis is performed via a central venous catheter.[1] While permanent arteriovenous fistulas are the preferred form of vascular access for hemodialysis patients, central venous catheters continue to serve as an important bridge to securing long-term ...
Armadillo is a radial platform of access catheters specifically designed to address the needs and challenges of radial access. ...
Q’Apel’s portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. ...
The company’s portfolio comprises two core products, the Walrus Balloon Guide Catheter (BGC) system, and the Wahoo Control™ Catheter hybrid access system. ...
Food and Drug Administration (FDA) for two product platforms: a family of access catheters called Large Distal Platform (LDP) designed to facilitate smooth, consistent navigation into blood vessels of the brain and the Zoom Aspiration System, a family of products designed to facilitate clot removal during ischemic stroke. ...
Q’Apel’s core portfolio comprises two products, the Walrus Balloon Catheter System and the Wahoo Hybrid Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. ...
The paper, published in Clinical Case Reports, adds to the body of evidence which supports the use of the Surfacer System to gain vascular access in patients who require venous access but have occlusions and damaged vessels which preclude the ability to access the central vasculature. ...
The company’s portfolio comprises two core products, the Walrus Balloon Guide Catheter (BGC) system, and the Wahoo Control™ Catheter hybrid access system. ...
Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of the results from the company’s prospective, multicenter SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Registry in the ...
In contrast, Avenu Medical's Ellipsys® Vascular Access System is a single-catheter, ultrasound-guided device that inserts a catheter percutaneously (through the skin) into the arm to create a durable AV fistula. ...